Zai Lab Limited - ADR

+6.51 (+10.17%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)6.73B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$54.83 Million
Adjusted EPS-$1.41
See more estimates
10-Day MA$71.49
50-Day MA$91.75
200-Day MA$135.70
See more pivots

Zai Lab Limited - ADR Stock, NASDAQ:ZLAB

Jinchuang Plaza, Building 1, 4/F, Shanghai, Shanghai 201210
Cayman Islands
Phone: +86.21.6163.2588
Number of Employees: 1194


Zai Lab Ltd. is a biopharmaceutical company. It engages in the discovering, licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need in the fields of oncology, infectious, and autoimmune diseases. The firm's products include Zejula and Optune. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.